Analyst Reco. MegaPro Biomedical Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
24.05 ^TWD	0.00%		-1.23%	-1.23%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

No results for this search